Ying Cheng Selected Research

Nausea

12/2022	Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial.
1/2021	Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort.
12/2020	Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer previously treated with crizotinib: Results from ASCEND-6.
1/2019	Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial.
12/2016	Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.
4/2014	Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Cheng Research Topics

Disease

144	Neoplasms (Cancer) 05/2024 - 11/2007
104	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2024 - 05/2012
46	Disease Progression 12/2023 - 05/2012
43	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2008
34	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 05/2014
31	Hypertension (High Blood Pressure) 05/2024 - 05/2005
29	Inflammation (Inflammations) 10/2023 - 08/2004
27	Lung Neoplasms (Lung Cancer) 04/2024 - 04/2014
24	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 10/2012
22	Infections 05/2024 - 11/2004
17	Breast Neoplasms (Breast Cancer) 10/2023 - 07/2010
16	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 09/2013
14	Stomach Neoplasms (Stomach Cancer) 03/2024 - 12/2008
13	Adenocarcinoma of Lung 12/2023 - 07/2013
12	Diarrhea 01/2023 - 01/2017
11	Hypoxia (Hypoxemia) 05/2024 - 05/2012
11	Adenocarcinoma 05/2024 - 02/2005
11	Brain Neoplasms (Brain Tumor) 04/2024 - 01/2017
11	Carcinoma (Carcinomatosis) 01/2023 - 12/2008
11	Type 2 Diabetes Mellitus (MODY) 03/2022 - 01/2019
10	Reperfusion Injury 01/2023 - 08/2004
10	Exanthema (Rash) 11/2022 - 05/2012
8	Body Weight (Weight, Body) 04/2024 - 12/2007
8	Neutropenia 12/2023 - 01/2018
8	Fibrosis (Cirrhosis) 01/2023 - 01/2018
7	COVID-19 05/2024 - 12/2020
7	Proteinuria 02/2024 - 01/2015
7	Cholestasis 01/2023 - 01/2015
7	Death (Near-Death Experience) 10/2021 - 12/2016
6	Pain (Aches) 04/2024 - 11/2008
6	Leukemia 11/2023 - 04/2016
6	Ischemia 08/2023 - 06/2008
6	Nausea 12/2022 - 04/2014
6	Hand-Foot Syndrome 01/2021 - 12/2008
5	Carcinogenesis 03/2024 - 04/2011
5	Thyroid Neoplasms (Thyroid Cancer) 10/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

44	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2005
33	ErbB Receptors (EGF Receptor)IBA 07/2024 - 06/2013
31	Tyrosine Kinase InhibitorsIBA 07/2024 - 06/2013
30	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2014
25	anlotinibIBA 10/2023 - 01/2018
21	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 12/2008
18	MicroRNAs (MicroRNA)IBA 02/2024 - 04/2011
18	Gefitinib (Iressa)FDA Link 11/2022 - 05/2012
17	PlatinumIBA 03/2024 - 05/2012
17	Messenger RNA (mRNA)IBA 03/2024 - 11/2004
14	Immune Checkpoint InhibitorsIBA 05/2024 - 09/2017
14	Therapeutic UsesIBA 03/2024 - 11/2011
14	Docetaxel (Taxotere)FDA Link 01/2024 - 07/2010
13	Alanine Transaminase (SGPT)IBA 02/2024 - 12/2008
13	osimertinibIBA 02/2024 - 11/2018
12	NivolumabIBA 02/2024 - 10/2017
11	LigandsIBA 04/2024 - 05/2014
11	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 02/2005
11	B7-H1 AntigenIBA 01/2023 - 11/2017
10	camrelizumabIBA 05/2024 - 01/2021
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 02/2005
10	CytokinesIBA 01/2023 - 11/2011
10	LipidsIBA 01/2022 - 02/2012
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 10/2012
9	Pemetrexed (MTA)FDA Link 02/2024 - 09/2014
9	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2009
9	Capecitabine (Xeloda)FDA Link 01/2023 - 12/2008
8	pembrolizumabIBA 04/2024 - 10/2017
8	Anaplastic Lymphoma KinaseIBA 04/2024 - 01/2019
8	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 09/2014
8	Bevacizumab (Avastin)FDA Link 01/2023 - 03/2012
8	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 06/2015
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2013
8	dicarboxydine (DCD)IBA 10/2021 - 12/2016
7	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2022
7	Hormones (Hormone)IBA 02/2024 - 01/2019
7	Gemcitabine FDA Link 11/2023 - 09/2014
7	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2015
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2014
7	apatinibIBA 01/2023 - 09/2013
7	Transcription Factors (Transcription Factor)IBA 07/2020 - 01/2015
6	Phosphotransferases (Kinase)IBA 05/2024 - 01/2017
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 09/2017
6	Long Noncoding RNAIBA 02/2024 - 01/2017
6	CrizotinibIBA 01/2024 - 01/2019
6	Angiotensin IIIBA 12/2023 - 09/2009
6	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 09/2010
6	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 03/2014
6	Insulin (Novolin)FDA Link 03/2022 - 05/2007
6	Blood Glucose (Blood Sugar)IBA 03/2022 - 12/2007
6	empagliflozinIBA 01/2022 - 01/2019
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2016
6	LipopolysaccharidesIBA 10/2021 - 10/2011
5	toripalimabIBA 05/2024 - 01/2022
5	Etoposide (VP 16)FDA LinkGeneric 03/2024 - 04/2016
5	6-methyladenineIBA 03/2024 - 01/2020
5	Monoclonal AntibodiesIBA 01/2024 - 12/2019
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 01/2015
5	Triglycerides (Triacylglycerol)IBA 11/2023 - 01/2012

Therapy/Procedure

107	Drug Therapy (Chemotherapy) 05/2024 - 12/2008
105	Therapeutics 05/2024 - 08/2003
25	Immunotherapy 05/2024 - 06/2014
10	Radiotherapy 12/2023 - 04/2014
6	Transplantation 05/2024 - 08/2004